nav-left cat-right
cat-right

Health Care’s Silent Spring

As the Intergovernmental Working Group (IGWG) of the WHO prepares to meet and discuss how to best facilitate the expropriation of intellectual property rights (in this case the IPR of pharmaceutical patents) it’s important to consider the unintended consequences — the death of medical innovation. The global purloiners of patents — led by Jamie Love — are thrilled to point out all of the new and...

Soon-to-be Laid Off Schering-Plough Employees

As reported in today’s Newark Star-Ledger, Schering-Plough’s New Jersey employees will bear the brunt of Fred Hassan’s plan to fire, terminate, let go with extreme prejudice, 5,500 people in S-P’s workforce: “Schering-Plough’s chief executive said yesterday the budget ax will fall first and hardest in New Jersey as the drugmaker cuts more than $1 billion in spending after the abrupt...

Roche deal tests drug cardiotoxicity on unique lab...

Roche has entered into an agreement to provide drug compounds for cardiotoxicity testing using a cell-based platform that could play a major role in the preclinical safety evaluation of drugs and newly developed compounds. The deal aims to detect any drug-induced changes in the electrical activity of the heart, such as prolongation of the QT interval, which could cause faster, slower, or irregular beating. Cardiotoxicity has...

Seaside Therapeutics Awards $4.5 Million Collabora...

Seaside Therapeutics announced today the award of a $4.5 million collaborative research contract to Vanderbilt University Medical Center to discover novel compounds to potentially suppress the manifestations of fragile X syndrome. Fragile X syndrome is the most common inherited disorder of brain development and the most common known genetic cause of autism. Individuals with fragile X can...

Profiling of Tumor Tissue Slices is Awarded Prize

Novel drug screening tool based on the Bionas® 2500 analyzing system wins silver medal in European business plan contest Rostock, Germany, November 26, 2007 / b3c newswire / – Bionas GmbH, a specialist for in vitro profiling the metabolic activity of cells, announced that Prof. Pedro Mestres of the Saarland University (Homburg/Saar, Germany) has been awarded the second prize in the business plan contest 1,2,3 GO for...

Znomics, Inc. Completes $4.88 Million Financing an...

PORTLAND, Ore., Nov. 27, 2007 (PRIME NEWSWIRE) — Znomics, Inc., a pioneer in the development of the zebrafish as a simple vertebrate genetic platform to accelerate drug discovery, announced the successful closing on November 5, 2007 of a $4.88 million private offering. Simultaneously with the close of the private offering, the company effected a merger with Pacific Syndicated Resources, Inc. (OTCBB:PSRI) and renamed the...
Page 10 of 19« First...89101112...Last »